Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $MRK vs $VTRS | Chartloom

Compare

$MRK vs $VTRS

Merck & Co Inc · Viatris Inc

MRK

Merck & Co Inc

VTRS

Viatris Inc

Compare $MRK vs $VTRS

Comparing Merck & Co Inc and Viatris Inc

MRKMerck & Co Inc

VTRSViatris Inc

MRKMerck & Co Inc

Market cap

$350.67B

P/E (TTM)

110.52x

Forward P/E (NTM)

16.48x

Forward P/S (NTM)

5.10x

Rev growth (TTM)

4.6%

YTD performance

33.4%

52W performance

65.1%

FCF yield

4.6%

VTRSViatris Inc

Market cap

$20.09B

P/E (TTM)

—

Forward P/E (NTM)

6.60x

Forward P/S (NTM)

1.33x

Rev growth (TTM)

4.4%

YTD performance

38.4%

52W performance

77.1%

FCF yield

9.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MRK

VTRS

Detailed metrics comparison

MRK

Merck & Co Inc

VTRS

Viatris Inc

Market Cap

MRK$350.67B

VTRS$20.09B

Enterprise Value

MRK$397.72B

VTRS$32.55B

Price

MRK$141.98

VTRS$17.25

P/E Ratio

MRK110.52x

VTRSN/A

P/S Ratio

MRK5.27x

VTRS1.36x

EV/Sales

MRK5.97x

VTRS2.21x

EV/EBITDA

MRK22.57x

VTRS8.00x

P/B Ratio

MRK8.57x

VTRS1.42x

P/FCF Ratio

MRK21.83x

VTRS11.09x

EV/FCF

MRK24.76x

VTRS17.96x

PEG Ratio

MRK17.81x

VTRSN/A

Forward P/E (NTM)

MRK16.48x

VTRS6.60x

Forward P/S (NTM)

MRK5.10x

VTRS1.33x

Revenue (TTM)

MRK$66.57B

VTRS$14.74B

Revenue Growth (YoY)

MRK4.6%

VTRS4.4%

Forward Rev Growth

MRK4.7%

VTRS2.0%

Gross Margin (TTM)

MRK77.3%

VTRS40.3%

Operating Margin (TTM)

MRK9.6%

VTRS0.0%

EBITDA Margin (TTM)

MRK26.3%

VTRS27.2%

Net Margin (TTM)

MRK4.8%

VTRS-2.8%

FCF Margin (TTM)

MRK24.1%

VTRS12.3%

Net Income (TTM)

MRK$3.17B

VTRS$-411M

FCF (TTM)

MRK$16.06B

VTRS$1.81B

EPS (TTM)

MRK$1.28

VTRS-$0.35

ROE (TTM)

MRK6.6%

VTRS-279.0%

ROA (TTM)

MRK2.4%

VTRS-112.0%

ROIC (TTM)

MRK3.3%

VTRS-142.0%

Cash

MRK$6.85B

VTRS$887M

Debt

MRK$53.91B

VTRS$13.35B

Net Cash/Debt

MRK$-47.06B

VTRS$-12.46B

Current Ratio (TTM)

MRK1.32x

VTRS1.58x

Quick Ratio (TTM)

MRK1.10x

VTRS0.83x

Debt/Equity (TTM)

MRK1.29x

VTRS0.94x

Debt/Assets (TTM)

MRK0.0%

VTRS0.0%

Interest Coverage (TTM)

MRKN/A

VTRSN/A

Net Debt/EBITDA (TTM)

MRK0.00x

VTRS0.00x

Beta

MRK0.12

VTRS0.89

52W Performance

MRK65.1%

VTRS77.1%

YTD Performance

MRK33.4%

VTRS38.4%

% from 52W High

MRK-9.5%

VTRS-6.4%

% from 52W Low

MRK73.1%

VTRS77.3%

Asset Turnover (TTM)

MRK0.51x

VTRS0.40x

FCF Yield (TTM)

MRK4.6%

VTRS9.0%

Earnings Yield (TTM)

MRK0.9%

VTRS-2.0%

Dividend Yield (TTM)

MRK2.3%

VTRS2.7%

Rule of 40

MRK28.8

VTRS16.7

EV/GP/RG

MRK2.37

VTRS1.97

Ticker research

View MRK research View VTRS research

Metric	MRK Merck & Co Inc	VTRS Viatris Inc
Market & Valuation
Market Cap	$350.67B	$20.09B
Enterprise Value	$397.72B	$32.55B
Price	$141.98	$17.25
P/E Ratio	110.52x	N/A
P/S Ratio	5.27x	1.36x
EV/Sales	5.97x	2.21x
EV/EBITDA	22.57x	8.00x
P/B Ratio	8.57x	1.42x
P/FCF Ratio	21.83x	11.09x
EV/FCF	24.76x	17.96x
PEG Ratio	17.81x	N/A
Forward P/E (NTM)	16.48x	6.60x
Forward P/S (NTM)	5.10x	1.33x
Revenue & Growth
Revenue (TTM)	$66.57B	$14.74B
Revenue Growth (YoY)	4.6%	4.4%
Forward Rev Growth	4.7%	2.0%
Profitability
Gross Margin (TTM)	77.3%	40.3%
Operating Margin (TTM)	9.6%	0.0%
EBITDA Margin (TTM)	26.3%	27.2%
Net Margin (TTM)	4.8%	-2.8%
FCF Margin (TTM)	24.1%	12.3%
Net Income (TTM)	$3.17B	$-411M
FCF (TTM)	$16.06B	$1.81B
EPS (TTM)	$1.28	-$0.35
ROE (TTM)	6.6%	-279.0%
ROA (TTM)	2.4%	-112.0%
ROIC (TTM)	3.3%	-142.0%
Financial Health
Cash	$6.85B	$887M
Debt	$53.91B	$13.35B
Net Cash/Debt	$-47.06B	$-12.46B
Current Ratio (TTM)	1.32x	1.58x
Quick Ratio (TTM)	1.10x	0.83x
Debt/Equity (TTM)	1.29x	0.94x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.12	0.89
52W Performance	65.1%	77.1%
YTD Performance	33.4%	38.4%
% from 52W High	-9.5%	-6.4%
% from 52W Low	73.1%	77.3%
Efficiency & Yields
Asset Turnover (TTM)	0.51x	0.40x
FCF Yield (TTM)	4.6%	9.0%
Earnings Yield (TTM)	0.9%	-2.0%
Dividend Yield (TTM)	2.3%	2.7%
Other
Rule of 40	28.8	16.7
EV/GP/RG	2.37	1.97
Ticker research	View MRK research	View VTRS research

Valuation

P/E Ratio

MRK

110.52x

P/S Ratio

VTRS

1.36x

MRK

5.27x

EV/FCF

VTRS

17.96x

MRK

24.76x

Growth & revenue

Revenue Growth TTM

MRK

4.6%

VTRS

4.4%

Forward Revenue Growth

MRK

4.7%

VTRS

2.0%

Profitability & performance

Gross Margin

MRK

77.3%

VTRS

40.3%

ROE

MRK

6.6%

VTRS

-279.0%

FCF Yield %

VTRS

9.0%

MRK

4.6%

52-Week Performance

VTRS

77.1%

MRK

65.1%

Detailed metrics comparison

MRK

Merck & Co Inc

VTRS

Viatris Inc

Market Cap

MRK$350.67B

VTRS$20.09B

Enterprise Value

MRK$397.72B

VTRS$32.55B

Price

MRK$141.98

VTRS$17.25

P/E Ratio

MRK110.52x

VTRSN/A

P/S Ratio

MRK5.27x

VTRS1.36x

EV/Sales

MRK5.97x

VTRS2.21x

EV/EBITDA

MRK22.57x

VTRS8.00x

P/B Ratio

MRK8.57x

VTRS1.42x

P/FCF Ratio

MRK21.83x

VTRS11.09x

EV/FCF

MRK24.76x

VTRS17.96x

PEG Ratio

MRK17.81x

VTRSN/A

Forward P/E (NTM)

MRK16.48x

VTRS6.60x

Forward P/S (NTM)

MRK5.10x

VTRS1.33x

Revenue (TTM)

MRK$66.57B

VTRS$14.74B

Revenue Growth (YoY)

MRK4.6%

VTRS4.4%

Forward Rev Growth

MRK4.7%

VTRS2.0%

Gross Margin (TTM)

MRK77.3%

VTRS40.3%

Operating Margin (TTM)

MRK9.6%

VTRS0.0%

EBITDA Margin (TTM)

MRK26.3%

VTRS27.2%

Net Margin (TTM)

MRK4.8%

VTRS-2.8%

FCF Margin (TTM)

MRK24.1%

VTRS12.3%

Net Income (TTM)

MRK$3.17B

VTRS$-411M

FCF (TTM)

MRK$16.06B

VTRS$1.81B

EPS (TTM)

MRK$1.28

VTRS-$0.35

ROE (TTM)

MRK6.6%

VTRS-279.0%

ROA (TTM)

MRK2.4%

VTRS-112.0%

ROIC (TTM)

MRK3.3%

VTRS-142.0%

Cash

MRK$6.85B

VTRS$887M

Debt

MRK$53.91B

VTRS$13.35B

Net Cash/Debt

MRK$-47.06B

VTRS$-12.46B

Current Ratio (TTM)

MRK1.32x

VTRS1.58x

Quick Ratio (TTM)

MRK1.10x

VTRS0.83x

Debt/Equity (TTM)

MRK1.29x

VTRS0.94x

Debt/Assets (TTM)

MRK0.0%

VTRS0.0%

Interest Coverage (TTM)

MRKN/A

VTRSN/A

Net Debt/EBITDA (TTM)

MRK0.00x

VTRS0.00x

Beta

MRK0.12

VTRS0.89

52W Performance

MRK65.1%

VTRS77.1%

YTD Performance

MRK33.4%

VTRS38.4%

% from 52W High

MRK-9.5%

VTRS-6.4%

% from 52W Low

MRK73.1%

VTRS77.3%

Asset Turnover (TTM)

MRK0.51x

VTRS0.40x

FCF Yield (TTM)

MRK4.6%

VTRS9.0%

Earnings Yield (TTM)

MRK0.9%

VTRS-2.0%

Dividend Yield (TTM)

MRK2.3%

VTRS2.7%

Rule of 40

MRK28.8

VTRS16.7

EV/GP/RG

MRK2.37

VTRS1.97

Ticker research

View MRK research View VTRS research

Metric	MRK Merck & Co Inc	VTRS Viatris Inc
Market & Valuation
Market Cap	$350.67B	$20.09B
Enterprise Value	$397.72B	$32.55B
Price	$141.98	$17.25
P/E Ratio	110.52x	N/A
P/S Ratio	5.27x	1.36x
EV/Sales	5.97x	2.21x
EV/EBITDA	22.57x	8.00x
P/B Ratio	8.57x	1.42x
P/FCF Ratio	21.83x	11.09x
EV/FCF	24.76x	17.96x
PEG Ratio	17.81x	N/A
Forward P/E (NTM)	16.48x	6.60x
Forward P/S (NTM)	5.10x	1.33x
Revenue & Growth
Revenue (TTM)	$66.57B	$14.74B
Revenue Growth (YoY)	4.6%	4.4%
Forward Rev Growth	4.7%	2.0%
Profitability
Gross Margin (TTM)	77.3%	40.3%
Operating Margin (TTM)	9.6%	0.0%
EBITDA Margin (TTM)	26.3%	27.2%
Net Margin (TTM)	4.8%	-2.8%
FCF Margin (TTM)	24.1%	12.3%
Net Income (TTM)	$3.17B	$-411M
FCF (TTM)	$16.06B	$1.81B
EPS (TTM)	$1.28	-$0.35
ROE (TTM)	6.6%	-279.0%
ROA (TTM)	2.4%	-112.0%
ROIC (TTM)	3.3%	-142.0%
Financial Health
Cash	$6.85B	$887M
Debt	$53.91B	$13.35B
Net Cash/Debt	$-47.06B	$-12.46B
Current Ratio (TTM)	1.32x	1.58x
Quick Ratio (TTM)	1.10x	0.83x
Debt/Equity (TTM)	1.29x	0.94x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.12	0.89
52W Performance	65.1%	77.1%
YTD Performance	33.4%	38.4%
% from 52W High	-9.5%	-6.4%
% from 52W Low	73.1%	77.3%
Efficiency & Yields
Asset Turnover (TTM)	0.51x	0.40x
FCF Yield (TTM)	4.6%	9.0%
Earnings Yield (TTM)	0.9%	-2.0%
Dividend Yield (TTM)	2.3%	2.7%
Other
Rule of 40	28.8	16.7
EV/GP/RG	2.37	1.97
Ticker research	View MRK research	View VTRS research